KLCM Advisors’s bluebird bio BLUE Stock Holding History

KLCM Advisors’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-906	Closed	-$499K	–	80
2016 Q1	$499K	Buy	+906	New	+$556K	0.17%	42

Other funds holding BLUE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

KLCM Advisors's BLUE Position: Q2 2016 in Review

KLCM Advisors sold out of bluebird bio (BLUE) in Q2 2016, closing a stake of 906 shares — an estimated $499K sold.

KLCM Advisors first reported a position in BLUE in Q1 2016 and held it in 1 quarter. The position peaked at $499K in Q1 2016. 177 funds tracked by Wall St. Rank hold BLUE as of Q2 2016.

KLCM Advisors reported no remaining bluebird bio position as of Q2 2016 after selling out during the quarter.
KLCM Advisors sold 906 bluebird bio shares in Q2 2016, an estimated $499K.
KLCM Advisors first reported a position in bluebird bio in Q1 2016 and held it in 1 quarter.
KLCM Advisors's bluebird bio position peaked at $499K in Q1 2016.
177 funds tracked by Wall St. Rank held bluebird bio as of Q2 2016.

Based on KLCM Advisors's 13F filing for Q2 2016, filed 8 Aug 2016.